| Dr Andrew Robert Benck, MD | |
|
2101 Waukegan Rd Ste 110, Bannockburn, IL 60015-1836 | |
| (847) 914-9096 | |
| Not Available |
| Full Name | Dr Andrew Robert Benck |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 2101 Waukegan Rd Ste 110, Bannockburn, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326574971 | NPI | - | NPPES |
| A158913 | Other | CA | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 036.156245 (Illinois) | Primary |
| 207R00000X | Internal Medicine | A158913 (California) | Secondary |
| Entity Name | Illinois Bone And Joint Institute Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205922432 PECOS PAC ID: 6002814878 Enrollment ID: O20061110000331 |
News Archive
Two innovative and highly successful models of care developed by nurses were the centerpiece of a briefing today on health care reform. The event, which brought together women's health leaders and health care experts, focused on the ways in which innovative health care models can help to improve efficiency, reduce costs and ensure quality care for patients and their families.
Today, the Damon Runyon Cancer Research Foundation held the fourth annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer.
Scientists have identified a potential new approach to treat human African trypanosomiasis (HAT), commonly known as sleeping sickness, which afflicts "tens of thousands of people in sub-Saharan Africa" annually, IRIN reports. By targeting an enzyme the sleeping sickness parasite needs in order to survive, researchers say they can kill it without causing harm to the patient (4/1).
Crayfish make surprisingly complex, cost-benefit calculations, finds a University of Maryland study, opening the door to a new line of research that may help unravel the cellular brain activity involved in human decisions.
The study is reported on July 17, 2013, in an advance online edition of the journal Nature, alongside a British laboratory's structural study of another member of the same class of receptors-known as "class B" G protein-coupled receptors (GPCRs).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Robert Benck, MD 2101 Waukegan Rd Ste 110, Bannockburn, IL 60015-1836 Ph: (847) 914-9096 | Dr Andrew Robert Benck, MD 2101 Waukegan Rd Ste 110, Bannockburn, IL 60015-1836 Ph: (847) 914-9096 |
News Archive
Two innovative and highly successful models of care developed by nurses were the centerpiece of a briefing today on health care reform. The event, which brought together women's health leaders and health care experts, focused on the ways in which innovative health care models can help to improve efficiency, reduce costs and ensure quality care for patients and their families.
Today, the Damon Runyon Cancer Research Foundation held the fourth annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer.
Scientists have identified a potential new approach to treat human African trypanosomiasis (HAT), commonly known as sleeping sickness, which afflicts "tens of thousands of people in sub-Saharan Africa" annually, IRIN reports. By targeting an enzyme the sleeping sickness parasite needs in order to survive, researchers say they can kill it without causing harm to the patient (4/1).
Crayfish make surprisingly complex, cost-benefit calculations, finds a University of Maryland study, opening the door to a new line of research that may help unravel the cellular brain activity involved in human decisions.
The study is reported on July 17, 2013, in an advance online edition of the journal Nature, alongside a British laboratory's structural study of another member of the same class of receptors-known as "class B" G protein-coupled receptors (GPCRs).
› Verified 2 days ago
Thomas A. Mayer, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2151 Waukegan Rd Ste 100, Bannockburn, IL 60015 Phone: 847-444-5300 Fax: 847-267-1429 | |
Dr. Adam Jeffrey Silver, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2151 Waukegan Rd Ste 100, Bannockburn, IL 60015 Phone: 847-444-5300 | |
David Jeremy Davidson, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2151 Waukegan Rd Ste 100, Bannockburn, IL 60015 Phone: 847-663-8410 Fax: 847-267-1429 | |
Jonathan M Gilbert, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2151 Waukegan Rd, Suite 100, Bannockburn, IL 60015 Phone: 847-444-5300 Fax: 847-267-0694 | |
David R Campbell, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2151 Waukegan Rd, Bannockburn, IL 60015 Phone: 847-444-5300 Fax: 847-267-0649 | |
Neil Stuart Freedman, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2151 Waukegan Rd, Suite 110, Bannockburn, IL 60015 Phone: 847-236-1300 Fax: 847-236-9549 | |
Benjamin D Margolis, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2151 Waukegan Rd Ste 110, Bannockburn, IL 60015 Phone: 847-236-1300 Fax: 847-236-9637 |